Oligonucleotide array-in-well platform for detection and genotyping human adenoviruses by utilizing upconverting phosphor label technology

Anal Chem. 2011 Feb 15;83(4):1456-61. doi: 10.1021/ac103155f. Epub 2011 Jan 24.

Abstract

We have developed a robust array-in-well test platform based on an oligonucleotide array, combining advantages of simple instrumentation and new upconverting phosphor reporter technology. Upconverting inorganic lanthanide phosphors have a unique property of photoluminescence emission at visible wavelengths under near-infrared excitation. No autofluorescence is produced from the sample or support material, enabling a highly sensitive assay. In this study, the assay is performed in standard 96-well microtiter plates, making the technique easily adaptable to high-throughput analysis. The oligonucleotide array-in-well assay is employed to detect a selection of ten common adenovirus genotypes causing human infections. The study provides a demonstration of the advantages and potential of the upconverting phosphor-based reporter technology in multianalyte assays and anti-Stokes photoluminescence detection with an anti-Stokes photoluminescence imaging device.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Absorption
  • Adenoviruses, Human / genetics*
  • Adenoviruses, Human / isolation & purification*
  • Adenoviruses, Human / physiology
  • Feasibility Studies
  • Genotype
  • HeLa Cells
  • Humans
  • Infrared Rays
  • Lanthanoid Series Elements / chemistry
  • Luminescent Agents / chemistry*
  • Luminescent Measurements / instrumentation*
  • Nasopharynx / virology
  • Oligonucleotide Array Sequence Analysis / methods*
  • Oligonucleotide Probes / chemistry
  • Oligonucleotide Probes / genetics
  • Particle Size
  • Photons
  • Reproducibility of Results

Substances

  • Lanthanoid Series Elements
  • Luminescent Agents
  • Oligonucleotide Probes